JP Morgan Chase
AXN

JP Morgan Chase’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

JP Morgan Chase’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-31
Closed – – 5266
2016
Q3 		$0 Hold
31
– – ﹤0.01% 5010
2016
Q2 		$0 Hold
31
– – ﹤0.01% 5124
2016
Q1 		$0 Hold
31
– – ﹤0.01% 5127
2015
Q4 		$0 Buy
+31
New +$39 ﹤0.01% 4896

Other funds holding AXN

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

JP Morgan Chase's AXN Position: Q4 2016 in Review

JP Morgan Chase sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q4 2016, closing a stake of 31 shares.

JP Morgan Chase first reported a position in AXN in Q4 2015 and held it in 4 quarters. The position peaked at $0 in Q3 2016. 11 funds tracked by Wall St. Rank hold AXN as of Q4 2016.

  • JP Morgan Chase reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Chase sold 31 Aoxing Pharmaceutical Company Inc. shares in Q4 2016.
  • JP Morgan Chase first reported a position in Aoxing Pharmaceutical Company Inc. in Q4 2015 and held it in 4 quarters.
  • JP Morgan Chase's Aoxing Pharmaceutical Company Inc. position peaked at $0 in Q3 2016.
  • 11 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q4 2016.

Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.